About Koerber Pharma Private Limited
Data last updated:
Koerber Pharma Private Limited is a foreign private limited company based in Navi Mumbai, Maharashtra, India, a subsidiary of Koerber Pharma Gmbh, Germany ((Formerly Koerber Medipak Systems Gmbh). It operates in the IT consulting and support services segment of the technology and IT services sector. It was incorporated on 26 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018FTC307130. Its GSTIN is 27AACCW1775F1Z8 (Maharashtra).
The company has an authorised share capital of ₹1.75 Cr and a paid-up capital of ₹1.61 Cr. It was formerly known as Koerber Medipak Systems India Private Limited and Werum It Solutions India Private Limited. It is led by directors Rajesh Chandrashekhar Vedak (Managing Director) and Oliver Stephan Werner Weber.
Its last annual general meeting (AGM) was held on 15 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 701 A Wing Reliable Tech Park Off Thane – Belapur Road Airoli, Navi Mumbai, Maharashtra, India – 400708.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.7 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹10.06 Cr (net margin 14.2%) and EBITDA of ₹15.86 Cr (EBITDA margin 22.4%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 57% over five years.
The company has about 107 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Körber Pharma. The company has 1 deal on record (1 rights issue); the latest was in December 2018. The company has 3 MSME Form 1 returns on record between 2021 and 2022, listing 7 overdue payments to 4 micro and small suppliers.
For more details, the company can be reached via its website koerber-pharma.com.
Company details
Name history
Koerber Pharma has undergone 2 name changes throughout its history. The company was previously known as Koerber Medipak Systems India Private Limited, and Werum It Solutions India Private Limited. The current legal name is Koerber Pharma Private Limited.
| Company Name | Status |
|---|---|
| Koerber Pharma Private Limited | Current |
| Koerber Medipak Systems India Private Limited | Previous |
| Werum It Solutions India Private Limited | Previous |
Contact details
Koerber Pharma Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is koerber-pharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address701 A Wing Reliable Tech Park Off Thane – Belapur Road Airoli, Navi Mumbai, Maharashtra, India – 400708
- IndustryInformation Technology, IT Consulting & Support Services
To see the full contact details of Koerber Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Koerber Pharma operates one associated brand: Körber Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Software development services are provided for the pharmaceutical industry. | koerber-pharma.com |
Business activity
The main business activity of Koerber Pharma is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Koerber Pharma Private Limited, buy the company report.
Financials of Koerber Pharma Private Limited
FY 2025 filings availableKoerber Pharma Private Limited reported revenue of ₹70.7 Cr (up 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 57% over five years, including 12% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹70.7 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.86 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.06 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.4% | ||||
| Net Profit Margin | 14.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Koerber Pharma Private Limited, buy the company report.
Board of directors of Koerber Pharma Private Limited
Koerber Pharma has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Chandrashekhar Vedak | Managing Director | 10 Sep 2019 | 7 Years 1 Months | Current |
| Oliver Stephan Werner Weber | Additional Director | 21 Apr 2025 | 1 Years 6 Months | Current |
Auditor
Koerber Pharma Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Chartered Accountants LLP | FY 2023 | 012754N/N500016 |
Shareholding
The shareholding of Koerber Pharma Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Koerber Pharma Private Limited, buy the company report.
Deals & funding
Koerber Pharma Private Limited has 1 deal on record (1 rights issue); the latest was in December 2018.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2018 | Rights issue | ₹1.46 Cr | Investors: Koerber Pharma Gmbh |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Koerber Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Koerber Pharma Private Limited has 3 MSME Form 1 returns on record between 2021 and 2022, listing 7 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Travel Deals 24X7 Private Limited | |||
| Kalyaniwalla & Mistry, LLP | |||
| Rac Infra Rental LLP |
To see the full MSME payment records of Koerber Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Koerber Pharma Private Limited has a workforce of 107 employees on its EPFO records as of Oct 10, 2025, across 1 active EPFO establishment.
GST
Koerber Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCW1775F1Z8 | Maharashtra | Active | 06 Sep 2018 |
To see the full GST registrations and return filing status of Koerber Pharma Private Limited, buy the company report.
Recent activity
Koerber Pharma Private Limited has 12 board changes on record since 2018: 4 appointments and 8 cessations. The latest: Oliver Stephan Werner Weber was appointed as Additional Director on 21 Apr 2025.
3 earlier events are in the company report.
News
Frequently asked questions
Koerber Pharma is an active foreign private limited company based in Navi Mumbai, Maharashtra, India. The company works in IT consulting and support services, within the information technology industry. It was incorporated on 26 March 2018 (8+ years old) and is registered under CIN U74999MH2018FTC307130.
Koerber Pharma has 2 current directors:
- Rajesh Chandrashekhar Vedak - Managing Director
- Oliver Stephan Werner Weber - Additional Director
The latest financial statements of Koerber Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 December 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Koerber Pharma is 27AACCW1775F1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of Koerber Pharma is U74999MH2018FTC307130. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Koerber Pharma was incorporated on 26 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Koerber Pharma has 1 deal on record (1 rights issue); the latest was in December 2018.
Oliver Stephan Werner Weber was appointed as Additional Director on 21 Apr 2025. Jens Karl Woehlbier ceased to be Additional Director on 29 Dec 2020. Jorn Olaf Gosse ceased to be Additional Director on 29 Dec 2020. Koerber Pharma has 12 board changes on record in total.
Koerber Pharma has 3 MSME Form 1 returns on record between 2021 and 2022, listing 7 overdue payments to 4 micro and small suppliers. The latest return was filed on 27 Apr 2022.
Koerber Pharma can be reached through the website koerber-pharma.com. Its registered office is in Navi Mumbai, Maharashtra, India.
The registered office of Koerber Pharma is at 701 A Wing Reliable Tech Park Off Thane – Belapur Road Airoli, Navi Mumbai, Maharashtra, India – 400708.